99mTc-Depreotide Scintigraphy Versus18F-FDG-PET in the Diagnosis of Radioiodine-Negative Thyroid Cancer

Abstract

Results indicate a potential value of (99m)Tc-depreotide scintigraphy for the diagnosis of thyroid cancer in the setting of detectable thyroglobulin and negative radioiodine scan. Furthermore, (99m)Tc-depreotide adds complementary information regarding the SSTR status of lesions, which may be helpful for individual therapy planning in this group of patients, which is hard to manage clinically.